-
Case Report Of Woman With Likely Byetta-Induced Acute Pancreatitis
August 2009 Medical Journal Article Presents Well-Documented Report Of Pancreatitis In Context Of Byetta Use (Posted by Tom Lamb at DrugInjuryWatch.com) In October 2007 the FDA announced that the agency had reviewed 30 postmarketing…
-
2006 Case Report Indicating That Xenical (Orlistat) May Cause Substantial Acute Liver Injury
Medical Journal Letter To Editor Stated That Exact Mechanism Of Hepatotoxicity In Subject Patient Was Unknown (Posted by Tom Lamb at DrugInjuryWatch.com) As we reported, on August 24, 2009 the FDA issued its "Early…
-
FDA Conducts A Self-Critical Analysis Of Its Early Communications (ECs) Program
There Was Apparently A Brief Discussion About Effect Of ECs At July 2009 Agency's Drug Safety Oversight Board Meeting The Public Summary for the July 16, 2009 meeting of the FDA's Drug Safety Oversight…
-
Some Users Of Alli And Xenical Have Developed Serious Liver Injury Including Liver Failure
FDA Early Communication Makes Clear That No Definite Association Between Liver Injury And Orlistat Has Been Established At This Time (Posted by Tom Lamb at DrugInjuryWatch.com) On May 22, 2009 we first reported that…
-
YAZ And Yasmin May Have Higher Risk Of Venous Thrombosis Than Older Birth Control Pills
Recent Studies Find That New Progestin Drospirenone Has 1.7 Times Increased Risk Of Developing Blood Clots Compared To Levonorgestrel (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________________________ UPDATE: "Bayer Affirms Safety Of YAZ / Yasmin…
-
A Theory Of How Yasmin Or YAZ Might Cause Pulmonary Embolism (PE) And Other Blood Clot Related Side Effects
Combination Of Ethinylestradiol And Drospirenone Increases Serum Copper, A Situation That Could Be Associated With Increased Cardiovascular Risk (Posted by Tom Lamb at DrugInjuryWatch.com) In the August 1, 2009 edition of the medical journal…
